The JSE had its sixth day of gains on Monday, its longest winning streak since January, as global investors cheered developments in the hunt for a Covid-19 vaccine, while focus will move to central banks later this week.

British-Swedish drugmaker AstraZeneca said at the weekend that it had resumed its phase-three vaccine trial in the UK.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now